A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Abroad (travel likely)RecruitingPHASE1

Conditions

Atopic Dermatitis · Hidradenitis Suppurativa (HS) · Rheumatoid Arthritis (RA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Third Hospital, Beijing, China
Contact: Study coordinator (Haiyan Li, M.D.) · haiyanli1027@hotmail.com · (+86) 18600489179
Contact: Study coordinator (Wenhui Wang, M.D.) · (+86) 15611908751

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers

Healthy Volunteer · Hidradenitis Suppurativa · Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

Atopic Dermatitis · Psoriasis · Hidradenitis Suppurativa

Abroad (travel likely)Recruiting

Paris, France

A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Shanghai, China · Shanghai, China

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Healthy Participants · Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Anaheim, United States · Miami, United States